Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.
By A. Kennedy, S. Nag, R. Salem, R. Murthy, A. McEwan, C. Nutting, A. Benson, Joseph Espat, J. Bilbao, Ricky A. Sharma and 2 more. International Journal of Radiation Oncology, Biology, Physics, 2007
702 citations recorded by the source corpus.
Subfields: Hepatology, Surgery
View Paper: https://www.semanticscholar.org/paper/3d47c217c8723c8d5e25256c9169a5e5370c1592
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Hepatology
Citations in the corpus
- Survival after yttrium‐90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation (2011, methodology): “0 g/dL), limited hepatic reserve, ascites, or other clinical signs of liver failure on physical examination.(23,24) However, under exceptional circumstances and with informed consent, some patients have been treated outside these criteria.”